These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives. Polak A; Jäckel A; Noack A; Kappe R Mycoses; 2004 Jun; 47(5-6):184-92. PubMed ID: 15189181 [TBL] [Abstract][Full Text] [Related]
4. Effect of oxiconazole and Ro 14-4767/002 on sterol pattern in Candida albicans. Polak-Wyss A; Lengsfeld H; Oesterhelt G Sabouraudia; 1985 Dec; 23(6):433-41. PubMed ID: 3913013 [TBL] [Abstract][Full Text] [Related]
5. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity]. Hiratani T; Yamaguchi H Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906 [TBL] [Abstract][Full Text] [Related]
6. The effect of the morpholine derivate amorolfin (Roche 14-4767/002) on the ultrastructure of Candida albicans. Müller J; Polak A; Jaeger R Mykosen; 1987 Nov; 30(11):528-40. PubMed ID: 3328047 [No Abstract] [Full Text] [Related]
7. [In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent]. Hiratani T; Asagi Y; Matsusaka A; Uchida K; Yamaguchi H Jpn J Antibiot; 1991 Sep; 44(9):993-1006. PubMed ID: 1960861 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of phagocytosis and intracellular killing of Candida albicans by human neutrophils in the presence of a morpholine antifungal derivative, Ro 14-4767. Richardson MD; Gray CA Ann N Y Acad Sci; 1988; 544():403-5. PubMed ID: 3063177 [No Abstract] [Full Text] [Related]
9. [Studies on experimental chemotherapy of dermatomycosis and candidiasis. X. Mechanism of the antifungal action of propiolic acid (beta-naphthyl)methyl ester]. Maeda T; Matui S; Hayashi M; Yamazoe H; Hayashi E Yakugaku Zasshi; 1986 Mar; 106(3):248-56. PubMed ID: 3522852 [No Abstract] [Full Text] [Related]
10. Morpholine antifungals and their mode of action. Mercer EI Biochem Soc Trans; 1991 Aug; 19(3):788-93. PubMed ID: 1783217 [No Abstract] [Full Text] [Related]
11. Thiophene congeners of morpholine and allylamine type antifungals--syntheses and biological activities. Bracher F; Papke T Pharmazie; 1995 Aug; 50(8):525-7. PubMed ID: 7568314 [TBL] [Abstract][Full Text] [Related]
12. [Relative inhibition factors: a new approach to the evaluation of antifungal antibiotics in vitro]. Odds FC Ann Dermatol Venereol; 1989; 116 Suppl 1():10-2. PubMed ID: 2688524 [No Abstract] [Full Text] [Related]
13. Mode of action of clinically important antifungal drugs. Kerridge D Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715 [No Abstract] [Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent. Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630 [TBL] [Abstract][Full Text] [Related]
15. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi. Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469 [TBL] [Abstract][Full Text] [Related]
16. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis. Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054 [TBL] [Abstract][Full Text] [Related]
17. Antifungal activity from Alpinia galanga and the competition for incorporation of unsaturated fatty acids in cell growth. Haraguchi H; Kuwata Y; Inada K; Shingu K; Miyahara K; Nagao M; Yagi A Planta Med; 1996 Aug; 62(4):308-13. PubMed ID: 8792660 [TBL] [Abstract][Full Text] [Related]